Anzeige
Mehr »
Donnerstag, 12.03.2026 - Börsentäglich über 12.000 News
Dieser 37-Mio.-€-Goldentwickler sitzt auf einem möglichen $2-Milliarden-Projekt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
270 Leser
Artikel bewerten:
(1)

Alira Health Announces Bill Achtmeyer and George G. Montgomery as Members of Board of Directors

FRAMINGHAM, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consultancy partnering with life sciences companies and patients to deliver evidence-based solutions, announced that Bill Achtmeyer and George G. Montgomery, MBA are serving as members of its Board of Directors. Mr. Montgomery was also elected Chairman of the Board.

Their service supports Alira Health's continued focus on advancing a differentiated, patient-centered model that integrates perspectives from those affected by disease into evidence generation, development strategy, access planning, and commercialization across the product lifecycle. Central to this approach are Alira Health's Patient-Enabled Solutions, which bring real-world insight into decision-making in a structured and scalable way.

Mr. Achtmeyer is the Chairman and Managing Partner of Acropolis Advisors, which he co-founded with Professor Michael Porter of Harvard Business School, and the former CEO and founder of The Parthenon Group, the global strategy consultancy that later merged with EY to form EY-Parthenon. He brings deep experience in strategy, governance, and the scaling of professional services organizations.

In his role on the Board, Mr. Achtmeyer supports Alira Health's emphasis on patient centricity and the structured involvement of patients in generating real-world evidence that informs regulatory strategy, market access, and commercial decision-making.

"I believe Gab is a trailblazer in this industry and has the passion and smarts to make Alira Health's value proposition into a sustainable competitive advantage," said Bill Achtmeyer.

Mr. Montgomery brings extensive experience across investment banking, operating leadership, and healthcare investing. He previously served as a Managing Director at JPMorgan H&Q and Cowen, held Board and Chief Financial Officer roles as a startup entrepreneur, and worked in private equity and venture capital investing at Gurnet Point Capital and WestRiver Group. As Chairman of the Board, Mr. Montgomery contributes strategic perspective focused on the quality, integration, and continuity of Alira Health's services across consulting, evidence generation, and CRO capabilities.

"Alira Health has built a platform that delivers consistently high-quality services across multiple disciplines," said George G. Montgomery. "The company's integrated model and focus on execution position it well to support clients across increasingly complex development and commercialization environments."

"We are pleased to have Bill and George serving on our Board," said Gabriele Brambilla, Chief Executive Officer of Alira Health. "Their perspectives align closely with our mission and are particularly valuable as we continue to scale our Patient-Enabled Solutions, integrating real-world insight into evidence generation, development strategy, access planning, and commercialization to better support our clients and the communities they serve."

Their participation further strengthens Alira Health's governance as the company continues to support life sciences organizations from early development through launch and commercialization.

About Alira Health

Alira Health is a global healthcare consultancy redefining evidence generation through patient partnership. By uniting strategic consulting, CRO services, and technology, the company supports life sciences organizations in accelerating development, improving access, and delivering measurable outcomes across the product lifecycle. To learn more about Alira Health, please visit alirahealth.com (https://alirahealth.com/).



Alira Health: Susan Irving - susan.irving@alirahealth.com

© 2026 GlobeNewswire (Europe)
Tech-Aktien schwanken – 3 Versorger mit Rückenwind
Die Stimmung an den Märkten hat sich grundlegend gedreht. Während Tech- und KI-Werte zunehmend mit Volatilität und Bewertungsrisiken kämpfen, erleben klassische Versorger ein unerwartetes Comeback. Laut IEA und EIA steigt der globale Strombedarf strukturell weiter, nicht nur wegen E-Mobilität und Wärmepumpen, sondern vor allem durch energiehungrige KI-Rechenzentren. Energie wird damit zur zentralen Infrastruktur des digitalen Zeitalters.

Gleichzeitig rücken in unsicheren Marktphasen stabile Cashflows, solide Bilanzen und regulierte Renditen wieder stärker in den Fokus. Genau hier spielen Versorger ihre Stärken aus: berechenbare Erträge, robuste Nachfrage und hohe Dividenden – Qualitäten, die vielen Wachstumswerten aktuell fehlen.

Nach Jahren im Schatten der Tech-Rallye steigt nun das Interesse an Unternehmen, die Stabilität mit langfristigen Wachstumsthemen wie Netzausbau, Dekarbonisierung und erneuerbaren Energien verbinden.

Im aktuellen Spezialreport stellen wir drei Versorger vor, die defensive Stärke mit attraktivem Potenzial kombinieren.

Jetzt den kostenlosen Report sichern – bevor die nächste Versorgerwelle Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.